Filing Details

Accession Number:
0001144204-12-047248
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-21 06:03:35
Reporting Period:
2012-08-20
Filing Date:
2012-08-21
Accepted Time:
2012-08-21 06:03:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1017491 Apricus Biosciences Inc. APRI Pharmaceutical Preparations (2834) 870449967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478733 Bassam Damaj 11975 El Camino Real,
Suite 300
San Diego CA 92130
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-20 1,500 $2.69 1,361,985 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The number of shares beneficially owned by the Reporting Person include 535,040 shares held jointly with spouse, as previously reported.